miRNAs in Amyotrophic Lateral Sclerosis: Tiny Molecules, Tremendous Impact

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with complex causes and variable progression.
• MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression, implicated in ALS pathogenesis.
• Dysregulated miRNAs are linked to neuromuscular dysfunction, neuroinflammation, and neuronal apoptosis in ALS.

Purpose of the Study:

• To review current research on miRNA-mediated mechanisms in ALS.
• To evaluate the diagnostic, prognostic, and therapeutic potential of miRNAs in ALS.
• To identify challenges and future directions for miRNA-based ALS therapies.

Main Methods:

• Literature review of recent studies on miRNAs in ALS.
• Synthesis of data on miRNA dysregulation and its role in ALS.
• Analysis of current miRNA-based therapeutic strategies and delivery methods.

Main Results:

• Specific miRNAs are dysregulated in ALS, correlating with disease mechanisms.
• miRNA mimics and inhibitors offer a network-based therapeutic approach for ALS.
• Challenges include efficient blood-brain barrier penetration and minimizing off-target effects of miRNA therapies.

Conclusions:

• miRNAs hold significant potential as biomarkers and therapeutic targets for ALS.
• Further research is needed to optimize delivery systems and validate miRNA strategies.
• Standardized protocols and multicenter validation are crucial for clinical translation in ALS precision medicine.